Immune Thrombocytopenia Market Size, Share, Growth and Trends Forecast to 2028
The global immune thrombocytopenia market is likely to derive growth from recent advancements in treatment methods of the disease. According to a report published by Fortune Business Insights, titled “ Immune Thrombocytopenia Market Size, Share & Industry Analysis, By Type (Acute Immune Thrombocytopenia, and Chronic Immune thrombocytopenia), By Treatment (Thrombopoietin Receptor Agonist, Immunoglobulins, Corticosteroids, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others) and Regional Forecast, 2019-2026 ,” the market was valued at USD 2.99 Billion in 2018, and is projected to reach USD 3.33 Billion by 2026, exhibiting a CAGR of 0.54% during the forecast period. Request a Sample Copy of the Global Immune Thrombocytopenia Market Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immune-thrombocytopenia-itp-market-101682 Some of the leading companies that are operating in the market are: Amgen Inc. Novarti...